Studies have uncovered the role of PCSK9 in the regulation of LDLR recycling and identified loss-of-function variants of PCSK9 associated with lower circulating LDL cholesterol levels and a reduced risk of coronary artery disease (2). Here, LDLR is linked to coronary artery disorder.